Abstract
Functionalised chromanone (4) is prepared by the condensation of aryldiazonium salt (2) and enaminones (1) in ethanol at room temperature. The structure of (4) was determined by spectral (IR, 1H and 13C NMR), elemental and X-ray diffraction analysis. Compound 4 (C18H15N3O3) crystallizes in the monoclinic space group P21/c with a = 7.9182(5), b = 21.729(2), c = 9.6217(7) Å, β = 97.293(6)°, V = 1642.0(2) Å3, Z = 4. The molecule of compound (4) is bent at the C-16 atom with a C15–O2–C16–C8 torsion angle of 46.18(3)°. Intramolecular phenolic N–H···O hydrogen bonds are also formed. Intermolecular hydrogen bonding and π–π stacking hold the molecules together. The average distance between stacked benzene ring planes is 4.488(12) Å. The preliminary POM analyses of 4 confirm the coexistence of two combined antibacterial and antiparasite pharmacophore sites. Therefore, compound 4 is promising and it should be screened without hesitation against virulent and pathogenic biotargets.
Similar content being viewed by others
References
S. Alam, J. Chem. Sci. 116, 325 (2004)
S. Aiello, G. Wells, E.L. Stone, H. Kadri, R. Bazzi, D.R. Bell, M.F.G. Stevens, C.S. Matthews, T.D. Bradshaw, A.D. Westwell, J. Med. Chem. 51, 5135 (2008)
V. Barve, F. Ahmed, S. Adsule, S. Banerjee, S. Kulkarni, P. Katiyar, C.E. Anson, A.K. Powell, S. Padhye, F.H. Sarkar, J. Med. Chem. 49, 3800 (2006)
C. Cano, O.R. Barbeau, C. Bailey, X.L. Cockcroft, N.J. Curtin, H. Duggan, M. Frigerio, B.T. Golding, I.R. Hardcastle, M.G. Hummersone, C. Knights, K.A. Menear, D.R. Newell, C.J. Richardson, G.C.M. Smith, B. Spittle, R.J. Griffin, J. Med. Chem. 53, 8498 (2010)
K. Hayashi, J. Mori, H. Saito, T. Hayashi, Biol. Pharm. Bull. 29, 1843 (2006)
P. Besse, G. Baziard-Mouysset, K. Boubekeur, P. Palvadeau, H. Veschambre, M. Payard, G. Mousset, Tetrahedron Asymmetry 10, 4745 (1999)
C.L. Chen, C.W. Lin, C.C. Hsieh, C.H. Lai, G.H. Lee, C.C. Wang, P.T. Chou, J. Phys. Chem. A 113, 205 (2009)
C. Conti, N. Desideri, Bioorg. Med. Chem. 18, 6480 (2010)
A.S. Demir, A. Aybey, O. Sesenoglu, F. Polat, Tetrahedron Asymmetry 14, 1489 (2003)
R.J. Griffin, G. Fontana, B.T. Golding, S. Guiard, I.R. Hardcastle, J.J.J. Leahy, N. Martin, C. Richardson, L. Rigoreau, M. Stockley, G.C.M. Smith, J. Med. Chem. 48, 569 (2005)
T. Keim, W. Francke, S. Schmidt, P. Fortnagel, J. Indust. Microbiol. Biotechnol. 23, 359 (1999)
M. Orita, S. Yamamoto, N. Katayama, M. Aoki, K. Takayama, Y. Yamagiwa, N. Seki, H. Suzuki, H. Kurihara, H. Sakashita, M. Takeuchi, S. Fujita, T. Yamada, A. Tanaka, J. Med. Chem. 44, 540 (2001)
A.M. Sobottka, W. Werner, G. Blaschke, W. Kiefer, U. Nowe, G. Dannhardt, E.E.S. Schapoval, E.P. Schenkel, G.K.E. Scriba, Arch. Pharm. Pharm. Med. Chem. 333, 205 (2000)
B. Bennani, A. Kerbal, M. Daoudi, B.F. Baba, G. Al-Houari, Jalbout, M. Mimouni, M. Benazza, G. Demailly, M. Akkurt, S.O. Yyldyrym, T. Ben Hadda, Arkivoc xvi, 19 (2007)
B. Bennani, A. Kerbal, B.F. Baba, M. Daoudi, I. Warad, M. Aljofan, A.M. Alafeefy, V.H. Masand, T. Ben Hadda, Med. Chem. Res. 22, 4798 (2013)
J. Sheikh, K. Hatzade, A. Bader, U. Shaheen, T. Sander, T. Ben Hadda, Med. Chem. Res. 23, 243 (2014)
K.M. Al-Zaydi, R.M. Borik, M.H. Elnagdi, Molecules 12, 2061 (2007)
K.M. Al-Zaydi, R.M. Borik, M.H. Elnagdi, Molecules 9, 910 (2004)
K.M. Al-Zaydi, R.M. Borik, M.H. Elnagdi, J. Heterocycl. Chem. 44, 1187 (2007)
K.M. Al-Zaydi, R.M. Borik, M.H. Elnagdi, Ultrason. Sonochem. 16, 660 (2009)
A. Altomare, G. Cascarano, C. Giacovazzo, A. Guagliardi, M.C. Burla, G. Polidori, M. Camalli, J. Appl. Crystallogr. 27, 435 (1994)
G.M. Sheldrick, SHELXL97: Program for the refinement of crystal structures. University of Göttingen, Germany, 1997
Z.H. Chohan, S.H. Sumrra, M.H. Youssoufi, T. Ben Hadda, Eur. J. Med. Chem. 45, 2739 (2010)
T. Ben Hadda, J. Fathi, I. Chafchaouni, V. Masand, Z. Charrouf, Z.H. Chohan, R. Jawarkar, T. Fergoug, I. Warad, Med. Chem. Res. 22, 1456 (2013)
T. Ben Hadda, R. Mouhoub, R. Jawarkar, V. Masand, I. Warad, Med. Chem. Res. 22, 2437 (2013)
T. Ben Hadda, A. Kerbal, B. Bennani, G.A. Houari, M. Daoudi, A.C.L. Leite, V.H. Masand, R.D. Jawarkar, Z. Charrouf, Med. Chem. Res. 22, 57 (2013)
T. Ben Hadda, H. Bendaha, J. Sheikh, M. Ahmad, I. Warad, Med. Chem. Res. 23, 1956 (2014)
T. Ben Hadda, S. Srivastava, B. Das, H. Salgado-Zamora, U. Shaheen, A. Bader, M.M. Naseer, Med. Chem. Res. 23, 995 (2014)
T. BenHadda, M. Ahmad, S. Sultana, U. Shaheen, A. Bader, S. Srivastava, B. Das, H. Salgado-Zamora, Med. Chem. Res. 23, 16 (2014)
J. Sheikh, A. Parvez, V. Ingle, H. Juneja, R. Dongre, Z.H. Chohan, M.H. Youssoufi, T. Ben Hadda, Eur. J. Med. Chem. 46, 1390 (2011)
J. Sheikh, A. Parvez, V. Ingle, H. Juneja, R. Dongre, Z.H. Chohan, M.H. Youssoufi, T. Ben Hadda, Eur. J. Med. Chem. 46, 1390 (2011)
S. Lahsasni, T. Ben Hadda, V.H. Masand, N.B. Pathan, A. Parvez, I. Warad, U. Shaheen, A. Bader, M. Aljofan, Res. Chem. Intermed. (2014). doi:10.1007/s11164-014-1616-7
Acknowledgments
We gratefully acknowledge the Department of Chemistry, Sciences Faculty for Girls at the King Abdulaziz University in Jeddah, Kingdom of Saudi Arabia for their support of this work.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Al-Zaydi, K., Alshehri, S.M. & Ben Hadda, T. Structure and POM analyses of 2-{(2Z)-2-[(2R)-2-ethoxy-4-oxo-2H-chromen-3(4H)-ylidene]hydrazinyl}benzonitrile with promising parasitological activity. Res Chem Intermed 42, 2201–2210 (2016). https://doi.org/10.1007/s11164-015-2143-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11164-015-2143-x